visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Ocera Therapeutics, Inc.

    Get Full Access

    Description

    • Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of OCR-002 (ornithine phenylacetate) in both intravenous and oral formulations. OCR-002 is an ammonia scavenger and has been granted orphan drug designation and Fast Track status by the U.S. Food and Drug Administration (FDA) for the treatment of hyperammonemia and resultant hepatic encephalopathy in patients with acute liver failure and acute-on-chronic liver disease. For additional information, please see www.ocerainc.com.We offer a competitive compensation and comprehensive benefits package including medical, dental, vision, life and disability insurance, a 401(k) plan and optional flexible spending accounts plus paid-time off and company holidays.
    • location

      Headquarters:525 University Avenue Suite 610, Palo Alto, California, United States

      More
    • Ocera Therapeutics, Inc. phone

      Phone Number: +1 650-475-0158

    • Ocera Therapeutics, Inc. website

      Website: https://www.ocerainc.com

    • Ocera Therapeutics, Inc. employees

      Employees:6

    • Ocera Therapeutics, Inc. revenue

      Revenue:$1 - 10M

    • Ocera Therapeutics, Inc. legal name

      Legal Name:Ocera Therapeutics, Inc.

    • Ocera Therapeutics, Inc.'s Social Media

      Ocera Therapeutics, Inc. linkedin
    • done Is this data correct?

    • |  NAICS Code: 541713  |

      Show More
    Person level website identification

    CEO for Ocera Therapeutics, Inc.

    Fischer Laurent

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Francois-Xavier Frapaise

    Chief Medical Officer

    Frequently Asked Questions regarding Ocera Therapeutics, Inc.

    • Where are Ocera Therapeutics, Inc.'s Headquarters?

      Ocera Therapeutics, Inc.'s Headquarters are in 525 University Avenue Suite 610,Palo Alto,California,United States

    • What is Ocera Therapeutics, Inc.'s phone number?

      Ocera Therapeutics, Inc.'s phone number is +1 650-475-0158

    • What is Ocera Therapeutics, Inc.'s official website?

      Ocera Therapeutics, Inc.'s official website is https://www.ocerainc.com

    • What is Ocera Therapeutics, Inc.'s Revenue?

      Ocera Therapeutics, Inc.'s revenue is $1 - 10M

    • What is Ocera Therapeutics, Inc.'s NAICS code?

      Ocera Therapeutics, Inc.'s NAICS code is 541713

    • How many employees are working in Ocera Therapeutics, Inc.

      Ocera Therapeutics, Inc. has 6 employees

    • What is Ocera Therapeutics, Inc.'s Industry?

      Ocera Therapeutics, Inc. is in the industry of Biotechnology

    • Who is Ocera Therapeutics, Inc.'s CEO?

      Ocera Therapeutics, Inc.'s CEO is Fischer Laurent

    Company Directory